Under construction – not a live service
Sign in
Taking people in TaiwanNo phase

Exercise Program for Muscle and Blood Sugar in Diabetes With Sarcopenia

Tests a 12-week exercise program in older adults with type 2 diabetes.

Plain-language title generated from the registry record
Registry title: Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia

Key facts

Where
Taichung, TaiwanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 45 and 85 years old?

Source: NCT07398495, who can take part

Where in Taiwan

  • Chung Shan Medical University HospitalTaichung, TaiwanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
yueh chu wu
Trial code
NCT07398495
Record updated
30 March 2026
Original description
This study aims to investigate the effects of a 12-week multimodal exercise intervention on middle-aged and older adults (aged 45~85 years) with Type 2 Diabetes Mellitus (T2DM). The program combines supervised training, home-based sessions, and digital support to improve muscle function, physical performance, metabolic control, and quality of life.Read full original descriptionShow less

Effects of Multimodal Training on Muscle Function and Glucose Metabolism in Middle-Aged and Older Adults With Type 2 Diabetes Mellitus and Sarcopenia

This study aims to investigate the effects of a 12-week multimodal exercise intervention on middle-aged and older adults (aged 45~85 years) with Type 2 Diabetes Mellitus (T2DM). The program combines supervised training, home-based sessions, and digital support to improve muscle function, physical performance, metabolic control, and quality of life.

Inclusion: Diagnosed with both Type 2 Diabetes Mellitus (T2DM) and sarcopenia; Maintained on a stable regimen of oral hypoglycemic agents; Aged 45 years or older; Capable of communicating effectively in Mandarin or Taiwanese; Willing to provide informed consent or have it obtained from a legally authorized representative.

Exclusion: • Limited limb or joint function that prevents exercise (e.g., recent fractures or dislocations); Communication barriers or severe emotional/psychological issues (e.g., uncontrolled depression or severe mental illness); Severe cognitive impairment (e.g., dementia); End-stage renal disease (ESRD); Major comorbidities or complications, including active diabetic foot ulcers, amputation, recent myocardial infarction, severe autonomic neuropathy, or a history of stroke within the last 3 years.

ClinicalTrials.gov NCT07398495